CLARIFICATION

CLARIFICATION Date: May 27, 1996 An item in the Notebook section of the April 29, 1996, issue of The Scientist (page 30) reported on a recent presentation by Godfrey Oakley, director of the division of birth defects and developmental disabilities at the Centers for Disease Control and Prevention in Atlanta, discussing folic acid taken by women of reproductive age. Oakley says the currently recommended 400 µg dose of folic acid per day is sufficient to prevent births of babie

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

An item in the Notebook section of the April 29, 1996, issue of The Scientist (page 30) reported on a recent presentation by Godfrey Oakley, director of the division of birth defects and developmental disabilities at the Centers for Disease Control and Prevention in Atlanta, discussing folic acid taken by women of reproductive age. Oakley says the currently recommended 400 µg dose of folic acid per day is sufficient to prevent births of babies with spina bifida and neural tube defects. However, he adds, the Food and Drug Administration recently required that as of Jan. 1, 1998, grain products be fortified with 140 µg folic acid per 100 g grain. This requirement is insufficient, according to Oakley, who recommends that grain products be fortified at about 700 µg per 100 g of grain.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies